Dr. Peranart Chotivitayatarakorn

Consultant

13 Years of Experience

Medical Gastroenterologist

MD, Diploma

English, Thai

Consultation Fee $ 20

WhatsApp Us

Dr. Peranart Chotivitayatarakorn is a gastroenterologist with 13 years of experience.
He offers state-of-the-art treatment for medical conditions such as normal and idiopathic chronic constipation, diarrhea, irritable bowel syndrome, and gastroesophageal reflux disease.
He holds expertise in performing surgical procedures like Whipple surgery and endoscopy.
Dr. Peranart Chotivitayatarakorn obtained an MD in Medicine from Chulalongkorn University, Thailand, in 2011.
He then pursued multiple diploma courses. He first obtained a Diploma in Internal Medicine from the Medical Council of Thailand in 2015, followed by a diploma in his field of expertise, i.e., gastroenterology, from Aichi Cancer Center Hospital, Japan, in the same year.
He also earned a Diploma in Gastroenterology from Thammasat University in 2017.
Additionally, Dr. Chotivitayatarakorn has received advanced therapeutic upper and lower GI endoscopy training from the Department of Gastroenterology, Aichi Cancer Center Hospital and Research Institute, Nagoya, Japan.
Further, he received training in high-resolution manometry from the GI Motility Workshop in 2015.
The doctor is an avid researcher, evidenced by his multiple publications. He is also a member of the Thai Medical Council.

Get a Treatment Plan Within 1 Hour

Name*

Mobile Number*

Query

MD in Medicine, Chulalongkorn University, Thailand, 2011
Diploma in Internal Medicine, Medical Council of Thailand, 2015
Diploma in Gastroenterology, Aichi Cancer Center Hospital, Japan, 2015
Diploma in Gastroenterology (Gastroenterological Diseases), Thammasat University, 2017

Certification of training in High-Resolution Manometry, GI Motility Workshop, 2015
Training in Advanced Therapeutic Upper and Lower GI Endoscopy, Gastroenterology, Aichi Cancer Center Hospital and Research Institute, Nagoya, Japan

He has around 16 publications to his credit, out of which the most recent ones are listed below:

Poonyam, P., Chotivitayatarakorn, P., & Vilaichone, R. K. (2019). High effectiveness of 14-day high-dose PPI-bismuth-containing quadruple therapy with probiotics supplement for Helicobacter pylori eradication: a double blinded-randomized placebo-controlled study. Asian Pacific journal of cancer prevention: APJCP, 20(9), 2859.
Auttajaroon, J., Vilaichone, R. K., Chotivitayatarakorn, P., & Mahachai, V. (2019). Once?daily rabeprazole, levofloxacin, clarithromycin?MR, and bismuth for Helicobacter pylori eradication: A randomized study of 7 or 14 days (ONCE study). Helicobacter, 24(5), e12615.
Limprukkasem, T., Chotivitayatarakorn, P., & Vilaichone, R. K. (2019). Mo1307 Clinical Predictors and Survival Rates of Diffuse and Intestinal Type of Gastric Cancer Patients: A 5-Year Longitudinal Study. Gastrointestinal Endoscopy, 89(6), AB482-AB483.
Aumpan, N., Vilaichone, R. K., Chotivitayatarakorn, P., Pornthisarn, B., Cholprasertsuk, S., Bhanthumkomol, P., ... & Mahachai, V. (2019). High efficacy of rapid urine test for diagnosis of Helicobacter pylori infection in Thai people. Asian Pacific Journal of Cancer Prevention: APJCP, 20(5), 1525.
Auttajaroon, J., Chotivitayatarakorn, P., Yamaoka, Y., & Vilaichone, R. K. (2019). CYP2C19 genotype, CagA genotype and antibiotic-resistant strain of Helicobacter pylori infection. Asian Pacific journal of cancer prevention: APJCP, 20(4), 1243